"For more than 30 years Gastroenterology Associates of Tidewater has been committed to providing the finest quality and compassionate care to our patients. All of our physicians are board-certified gastroenterologists and use the most comprehensive state of the art medical equipment available. Our diverse backgrounds and medical expertise of specialty procedures set our practice apart from our peers. We believe in providing state-of-the-art medical expertise with an integrated team approach to healthcare delivery."

During the past decade, Gastroenterology Associates of Tidewater conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 20 clinical trials were completed, i.e. on average, 74.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 12 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastroenterology Associates of Tidewater" #1 sponsor was "Medtronic - MITG" with 7 trials, followed by "Bausch Health Americas, Inc." with 5 trials sponsored, "Galapagos NV" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastroenterology Associates of Tidewater" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Premier Research Group plc" with 2 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Gastroenterology Associates of Tidewater" are "Ulcerative Colitis" (11 trials), "Crohn's Disease" (6 trials), "Colitis, Ulcerative" (5 trials), "Colorectal Cancer" (4 trials) and "Crohn Disease" (4 trials). Many other conditions were trialed in "Gastroenterology Associates of Tidewater" in a lesser frequency.

Most popular intervention types in "Gastroenterology Associates of Tidewater" are "Drug" (34 trials), "Device" (6 trials), "Other" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Filgotinib" (5 trials), "Guselkumab Dose 1" (3 trials), "Guselkumab Dose 2" (3 trials) and "Colonoscopy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gastroenterology Associates of Tidewater" are 46 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Gastroenterology Associates of Tidewater". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in Gastroenterology Associates of Tidewater, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Gastroenterology Associates of Tidewater, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".